MRNY vs. MRNA
MRNY (YieldMax MRNA Option Income Strategy ETF) is Derivative Income fund actively managed by YieldMax, while MRNA (Moderna, Inc.) is a stock. Over the past year, MRNY returned 60.66% vs 98.59% for MRNA. Their 0.97 correlation means they have historically moved very closely together.
Performance
MRNY vs. MRNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MRNY achieves a 60.69% return, which is significantly lower than MRNA's 85.89% return.
MRNY
- 1D
- -4.13%
- 1M
- -26.21%
- 6M
- 15.78%
- YTD
- 60.69%
- 1Y
- 60.66%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -22.32%
MRNA
- 1D
- -5.35%
- 1M
- -31.27%
- 6M
- 24.39%
- YTD
- 85.89%
- 1Y
- 98.59%
- 3Y*
- -21.64%
- 5Y*
- -31.12%
- 10Y*
- —
- ALL TIME*
- 12.68%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
MRNA Moderna, Inc. | $279.32M | $443.27M | $449.57M |
| $2.54M | $3.80M | $3.20M |
MRNY vs. MRNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
MRNY YieldMax MRNA Option Income Strategy ETF | 60.69% | -35.72% | -59.32% | 18.27% |
MRNA Moderna, Inc. | 85.89% | -29.08% | -58.19% | 26.46% |
Correlation
The correlation between MRNY and MRNA is 0.98 - they have historically moved very closely together. At this level, their price movements offset little of one another.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.98 |
Correlation (All Time) Calculated using the full available price history since Oct 24, 2023 | 0.97 |
The correlation between MRNY and MRNA has been stable across timeframes, ranging from 0.97 to 0.98 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRNY vs. MRNA — Risk / Return Rank
MRNY
MRNA
MRNY vs. MRNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for YieldMax MRNA Option Income Strategy ETF (MRNY) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MRNY | MRNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.30 | ||
| Sortino ratioReturn per unit of downside risk | -0.42 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.24 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 1.73 | 2.53 | -0.80 |
| Martin ratioReturn relative to average drawdown | 5.11 | 6.75 | -1.65 |
Loading charts...
Drawdowns
MRNY vs. MRNA - Drawdown Comparison
The maximum MRNY drawdown since its inception was -82.15%, smaller than the maximum MRNA drawdown of -95.38%. Use the drawdown chart below to compare losses from any high point for MRNY and MRNA.
Loading charts...
Drawdown Indicators
| MRNY | MRNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.15% | -95.38% | +13.23% |
Max Drawdown (1Y)Largest decline over 1 year | -28.84% | -33.90% | +5.06% |
Max Drawdown (3Y)Largest decline over 3 years | — | -86.58% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -95.38% | — |
Current DrawdownCurrent decline from peak | -66.17% | -88.68% | +22.51% |
Average DrawdownAverage peak-to-trough decline | -53.18% | -57.57% | +4.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.47% | 13.82% | -2.35% |
Volatility
MRNY vs. MRNA - Volatility Comparison
The current volatility for YieldMax MRNA Option Income Strategy ETF (MRNY) is 17.82%, while Moderna, Inc. (MRNA) has a volatility of 22.40%. This indicates that MRNY experiences smaller price fluctuations and is considered to be less risky than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MRNY | MRNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.82% | 22.40% | -4.58% |
Volatility (6M)Calculated over the trailing 6-month period | 36.53% | 48.29% | -11.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 53.56% | 69.43% | -15.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 51.54% | 67.00% | -15.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 51.54% | 72.39% | -20.85% |
Dividends
MRNY vs. MRNA - Dividend Comparison
MRNY's dividend yield for the trailing twelve months is around 101.63%, while MRNA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
MRNA Moderna, Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
MRNY YieldMax MRNA Option Income Strategy ETF | 101.63% | 145.98% | 178.49% | 1.75% |
Frequently Asked Questions
With a correlation of 0.98, MRNY and MRNA move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
MRNA has higher volatility (22.40%) compared to MRNY (17.82%). In terms of maximum drawdown, MRNY dropped -82.15% vs MRNA's -95.38%.
MRNA currently has the higher Sharpe Ratio (1.25 vs 0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MRNY and MRNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer